交大昂立(600530.SH)擬投資1000萬元設立孫公司霍爾果斯公司
格隆匯3月26日丨交大昂立(600530.SH)公佈,為滿足公司戰略發展需要,進一步擴展公司業務規模,公司擬以下屬全資子公司上海仁杏健康管理有限公司(以下簡稱“上海仁杏”)為出資主體對外投資設立其全資子公司霍爾果斯仁杏健康管理有限公司(以下簡稱“霍爾果斯公司”),註冊資本人民幣1000萬元。設立完成後霍爾果斯公司將成為公司全資孫公司。經營範圍包括健康管理諮詢;企業管理諮詢;養老服務;商務諮詢;工程管理服務; 人力資源諮詢服務等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.